AKTA PHARMACEUTICAL DEVELOPMENT
Dead / Cancelled — Cancelled — Section 18 (TTAB) (as of 08 Apr 2021)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86689132
- Registration number
- 5193775
- Mark type
- Design + words
- Filed
- 10 Jul 2015
- Published for opposition
- 14 Feb 2017
- Registered
- 02 May 2017
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields
Owner
- akta Pharmaceutical Development LLC, Boston, MA, US
- akta Pharmaceutical Development LLC, Boston, MA, US
- akta Pharmaceutical Development LLC, Boston, MA, US
Prosecution history
- 08 Apr 2021 — CANCELLED SECTION 18-TOTAL
- 08 Apr 2021 — CANCELLATION TERMINATED NO. 999999
- 08 Apr 2021 — CANCELLATION GRANTED NO. 999999
- 07 Jan 2021 — CANCELLATION INSTITUTED NO. 999999
- 02 May 2017 — REGISTERED-PRINCIPAL REGISTER
- 14 Feb 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Feb 2017 — PUBLISHED FOR OPPOSITION
- 25 Jan 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Jan 2017 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 23 Dec 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Dec 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Dec 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Dec 2016 — ASSIGNED TO LIE
- 10 Nov 2016 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 11 May 2016 — NOTIFICATION OF FINAL REFUSAL EMAILED